Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Huntsman

Showing results (181-190 of 320) with videos related to

Pageof 32
Sort By:
The Journal of Pathology|June 19, 2013
Familial rhabdoid tumour 'avant la lettre'--from pathology review to exome sequencing and back againLeora Witkowski, Emilie Lalonde, Jian Zhang, et al.
Breast Cancer Research and Treatment|October 4, 2007
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 casesDmitry A Turbin, Samuel Leung, Maggie C U Cheang, et al.
Frontiers in Oncology|January 8, 2024
A tumor-restricted glycoform of podocalyxin is a highly selective marker of immunologically cold high-grade serous ovarian carcinomaJulyanne Brassard, Michael R Hughes, Pamela Dean, et al.
Human Pathology|June 21, 2019
Expression of L1 retrotransposon open reading frame protein 1 in gynecologic cancersZhouchunyang Xia, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
Cancer Research|April 16, 2009
PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancerRobert J Crowder, Chanpheng Phommaly, Yu Tao, et al.
Oncogene|July 20, 2005
NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosisLeah M Prentice, Ashleen Shadeo, Valia S Lestou, et al.
BMC Cancer|January 23, 2008
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalitiesJoshua Z Press, Alessandro De Luca, Niki Boyd, et al.
The Journal of Pathology|February 19, 2015
Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burdenMichael S Anglesio, Ali Bashashati, Yi Kan Wang, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
Lessons from a National Liquid Biopsy Program to Provide Cancer Testing and Treatment for Patients with Advanced Solid TumorsAnna Lapuk, Benjamin L S Furman, Pedro Feijao, et al.
Scientific Reports|September 7, 2017
Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baitsMiguel Alcaide, Stephen Yu, Jordan Davidson, et al.
Pageof 32

Showing results (181-190 of 320) with videos related to

Sort By:
Pageof 32
The Journal of Pathology|June 19, 2013
Familial rhabdoid tumour 'avant la lettre'--from pathology review to exome sequencing and back againLeora Witkowski, Emilie Lalonde, Jian Zhang, et al.
Breast Cancer Research and Treatment|October 4, 2007
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 casesDmitry A Turbin, Samuel Leung, Maggie C U Cheang, et al.
Frontiers in Oncology|January 8, 2024
A tumor-restricted glycoform of podocalyxin is a highly selective marker of immunologically cold high-grade serous ovarian carcinomaJulyanne Brassard, Michael R Hughes, Pamela Dean, et al.
Human Pathology|June 21, 2019
Expression of L1 retrotransposon open reading frame protein 1 in gynecologic cancersZhouchunyang Xia, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
Cancer Research|April 16, 2009
PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancerRobert J Crowder, Chanpheng Phommaly, Yu Tao, et al.
Oncogene|July 20, 2005
NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosisLeah M Prentice, Ashleen Shadeo, Valia S Lestou, et al.
BMC Cancer|January 23, 2008
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalitiesJoshua Z Press, Alessandro De Luca, Niki Boyd, et al.
The Journal of Pathology|February 19, 2015
Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burdenMichael S Anglesio, Ali Bashashati, Yi Kan Wang, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
Lessons from a National Liquid Biopsy Program to Provide Cancer Testing and Treatment for Patients with Advanced Solid TumorsAnna Lapuk, Benjamin L S Furman, Pedro Feijao, et al.
Scientific Reports|September 7, 2017
Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baitsMiguel Alcaide, Stephen Yu, Jordan Davidson, et al.
Pageof 32